Chromosomal location of murine Disabled-2 gene and structural comparison with its human ortholog

Gene

Volumn 268, Issue 1-2, 2001, Pages 31-39

  Sheng, Zejuan ^a   Smith, Elizabeth R ^b   He, Junqi ^a   Tuppen, Joseph A ^d   Martin, W David ^c   Dong, Feng B ^d   Xu, Xiang Xi ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

BAC clone; CpG islands; Disabled 2 (Dab2); Gene structure; Mouse chromosome 15A2; MT repeats; Promoter; Transcription regulation

Indexed keywords

COMPLEMENTARY DNA; PHOSPHOPROTEIN; PROTEIN DAB2; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOMAL LOCALIZATION; CHROMOSOME MAP; CONTROLLED STUDY; DROSOPHILA; EXON; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE ISOLATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC CODE; INTRON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RNA TRANSLATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSLATION INITIATION;

ANIMALS; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; EXONS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035795631     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(01)00401-2     Document Type: Article

References (33)

1. Albertsen H.M., Smith S.A., Melis R., William B., Holik P., Stevens J., White R. Sequence, genomic structure and chromosomal assignment of human DOC-2. Genomics. 33:1996;207-213.
2. Bastien L., Bourgaux P. The MT family of mouse DNA is made of short interspersed repeated elements. Gene. 57:1987;81-88.
3. Cho S.Y., Park S.S. Genomic organization and promoter analysis of mouse disabled 2 gene. Biochem. Biophys. Res. Commun. 275:2000;189-194.
4. Cho S.Y., Cho S.Y., Lee S.H., Park S.S. Differential expression of mouse Disabled 2 gene in retinoic acid-treated F9 embryonal carcinoma cells and early mouse embryos. Mol. Cells. 30:1999;179-184.
5. Fazili Z., Mittelstaedt S., Sun W., Cohen C., Xu X.X. Disabled-2 inactivation is an early step in ovarian tumorigenicity. Oncogene. 18:1999;3104-3113.
6. Fazili, Z., Sheng, Z., Sun, W., Cohen, C., Mendez, L.E., Horowitz, I.R., Xu, X.X., 2001. Disabled-2 gene inactivation by homozygous deletion in breast and ovarian tumors, submitted.
7. Fickett J.W., Hatzigeorgiou A.G. Eukaryotic promoter recognition. Genome Res. 7:1997;861-878.
8. Gertler F.B., Bennett R.L., Clark M.L., Hoffmann F.M. Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell. 58:1989;103-113.
9. Gertler F.B., Hill K.H., Clark M.L., Hoffmann F.M. Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate. Genes Develop. 7:1993;441-453.
10. Hoffmann F.M. Drosophila abl and genetic redundancy in signal transduction. Trends Genet. 7:1991;351-355.
11. Howell B.W., Gertler F.B., Cooper J.A. Mouse disabled (mDab1): a Src binding protein implicated in neuronal development. EMBO J. 16:1997;121-132.
12. Howell B.W., Hawkes R., Soriano P., Cooper J.A. Neuronal position in the developing brain is regulated by mouse Disabled-1. Nature. 389:1997;733-737.
13. Huber R., Schlessinger D., Pilia G. Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene. Gene. 214:1998;35-44.
14. Knudsen S. Promoter2.0: for the recognition of PolII promoter sequences. Bioinformatics. 15:1999;356-361.
15. de Lambert R.C., Goffinet A.M. Cloning of human DAB1 and mapping to chromosome 1p31-p32. Genomics. 53:1998;246-247.
16. Mok S.C., Wong K.K., Chan R.K., Lau C.C., Tsao S.W., Knapp R.C., Berkowitz R.S. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol. Oncol. 52:1994;247-252.
17. Mok S.C., Chan W.Y., Wong K.K., Cheung K.K., Lau C.C., Ng S.W., Baldini A., Colitti C.V., Rock C.O., Berkowitz R.S. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene. 16:1998;2381-2387.
18. Morrisey E.E., Musco S., Chen M.Y., Lu M.M., Leiden J.M., Parmacek M.S. The gene encoding the mitogen-responsive phosphoprotein Dab2 is differentially regulated by GATA-6 and GATA-4 in the visceral endoderm. J. Biol. Chem. 275:2000;19949-19954.
19. Prestridge D.S. SIGNAL SCAN: a computer program that scans DNA sequences for eukaryotic transcriptional elements. Comput. Appl. Biosci. 7:1991;203-206.
20. Prestridge D.S. Prediction of Pol II Promoter sequences using transcription factor binding sites. J. Mol. Biol. 249:1995;923-932.
21. Prestridge D.S. SIGNAL SCAN 4.0: additional databases and sequence formats. Comput. Appl. Biosci. 12:1996;157-160.
22. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector - New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884.
23. Reese M.G., Eeckman F.H. New neural network algorithms for improved eukaryotic promoter site recognition. Genome Sci. Technol. 1:1995;45.
24. Schwahn D.J., Medina D. p96, a MAPK-related protein, is consistently downregulated during mouse mammary carcinogenesis. Oncogene. 17:1998;1173-1178.
25. Sheldon M., Rice D.S., D'Arcangelo G., Yoneshima H., Nakajima K., Mikoshiba K., Howell B.W., Cooper J.A., Goldowitz D., Curran T. Scrambler and Yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature. 389:1997;730-733.
26. Sheng Z., Sun W., Smith E., Cohen C., Sheng Z., Xu X.X. Restoration of positioning control by Disabled-2 expression in breast and ovarian tumor cells. Oncogene. 19:2000;4847-4854.
27. Sheng Z., He J., Tuppen J.A., Sun W., Fazili Z., Smith E.R., Dong F.B., Xu X.X. Structure, sequence and promoter analysis of human Disabled-2 gene. Genomics. 70:2000;381-386.
28. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., Herz J. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell. 97:1999;689-701.
29. Tseng C.P., Ely B.D., Li Y., Pong E.C., Hsieh J.T. Regulation of rat DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells. Endocrinology. 139:1998;3542-3553.
30. Ware M.L., Fox J.W., Gonzalez J.L., Davis N.M., Lambert de Rouvroit C., Russo C.J., Chua S.C. Jr, Goffinet A.M., Walsh C.A. Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse. Neuron. 19:1997;239-249.
31. Xu X.X., Yang W., Jackowski S., Rock C.O. Molecular cloning of a CSF-1 regulated protein with a domain homologous to Drosophila disabled. J. Biol. Chem. 270:1995;14184-14191.
32. Xu X.X., Yi T., Tang B., Lambeth J.D. Disabled-2 is an SH3 domain binding partner of Grb2. Oncogene. 16:1998;1561-1569.
33. Zuber J., Tchernitsa O.I., Hinzmann B., Schmitz A.C., Grips M., Hellriegel M., Sers C., Rosenthal A., Schafer R. A genome-wide survey of RAS transformation targets. Nat. Genet. 24:2000;144-152.